Pancreatic Enzyme Replacement Therapy
Customize your policy alerts
Sign up for blue cross blue shield - louisiana Policy 00981 alerts
Get alerted when Policy 00981 changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage eligibility for Pancreaze and Pertzye for pancreatic enzyme replacement therapy in eligible members of Blue Cross and Blue Shield of Louisiana and HMO Louisiana, Inc. Coverage requires applicable plan benefits and satisfaction of the policy's medical necessity and preferred-product trial criteria.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.